ATC

Clinical trials for ATC explained in plain language.

Never miss a new study

Get alerted when new ATC trials appear

Sign up with your email to follow new studies for ATC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo shows promise against hard-to-treat cancers

Disease control Completed

This early-phase study tested a new drug called CFT1946 in 89 adults with BRAF V600 mutant solid tumors (like melanoma, lung, or colon cancer). The goal was to find safe doses and see if the drug works alone or with other medicines (trametinib or cetuximab). Researchers monitored…

Matched conditions: ATC

Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control

Last updated Jun 09, 2026 12:06 UTC

ATC

Get alerted when new ATC trials appear

New drug combo shows promise against hard-to-treat cancers